SARS News and Research

RSS

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Researchers assessed the levels of neutralizing antibodies in coronavirus disease patients.

9 Mar 2022

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

A recent study evaluated the positivity rates of COVID-19 rapid antigen tests in infected individuals.

9 Mar 2022

The relationship between highly conserved residues in the SARS CoV fusion peptide and their role in coordinating calcium binding for viral entry

Researchers evidenced the significance of calcium in mediating the interaction between the coronaviruses fusion peptide and host cell membrane to provide insights into the mechanisms of viral entry.

9 Mar 2022

High prevalence of new-onset diabetes with ketoacidosis observed in children during COVID-19 pandemic

Research revealed the incidence of type 1 diabetes mellitus with severe diabetic ketoacidosis has increased among genetically susceptible children during the COVID-19 pandemic.

9 Mar 2022

A predictive model for COVID-19 outcomes

A new technique to solve unbalanced problems for the efficient management of SARS-CoV-2 infected patients according to comorbidities, age, and sex.

9 Mar 2022

CRIPSR identifies cell-type-specific ACE2 modifiers

Researchers compile a list of candidate genes to identify the surface abundance of functional regulators of ACE2.

9 Mar 2022

Increasing trend of antimicrobial resistance in Eastern Mediterranean Region of World Health Organization

Researchers investigated the rising antimicrobial resistance in the Eastern Mediterranean Region of the World Health Organization from 2017 to 2019.

9 Mar 2022

Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

In a new study, researchers conducted a retrospective analysis of the SAR-CoV-2 reverse transcriptase - quantitative polymerase chain reaction test measurements.

9 Mar 2022

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Researchers assessed the diabetogenic potential of SARS-CoV-2 in a single cell in vitro analysis on the pancreatic islet cells.

9 Mar 2022

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

A new study provides an overview of the use of mathematical modeling to determine severe acute respiratory syndrome coronavirus 2 kinetics.

9 Mar 2022

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

Researchers conducted virtual screening and validation of molecules derived from mushrooms for their activity against the main protease SARS-CoV-2.

9 Mar 2022

One California university has unified town and gown to fight covid. Why haven’t others?

Once a week, Lori Janich drives down the street from her office and partakes in an ongoing success story. Phone in hand to confirm her appointment, she strolls into the massive Activities and Recreation Center on the University of California-Davis campus, reaches a covid-19 testing station, swirls water in her mouth, spits into a tube, and leaves. Within a day, she receives her test result.

9 Mar 2022

Elevated P2X7 receptor levels in COVID-19 patients correlate with disease severity

In a recent study posted to the bioRxiv preprint server, researchers demonstrated that the soluble P2X7 receptor is increased in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients. They also showed that the elevated P2X7 receptors correlated with coronavirus disease 2019 (COVID-19) severity.

9 Mar 2022

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that the lower expression of EXOSC2 human protein safeguards from clinical coronavirus disease 2019 (COVID-19). This protective effect was via the reduced EXOSC2 expression-associated suppression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication.

9 Mar 2022

Assessment of oligonucleotides as COVID-19 treatment

A recent study posted to the bioRxiv* pre-print server assessed the ability of oligonucleotides in preventing the development of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions.

8 Mar 2022

Challenges and solutions for long-COVID

A recent study published in the Annals of Internal Medicine investigated the challenges and solutions associated with the unbiased estimation of post coronavirus disease 2019 (COVID-19) sequelae.

8 Mar 2022

COVID-19 may cause brain shrinkage in some people

In a recent study posted to the journal Nature as an unedited manuscript, researchers assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated brain changes among United Kingdom (UK) Biobank patients.

8 Mar 2022

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new study published in the Journal of Infectious Diseases shines an unexpected light on the notion that pre-existing immunity to common cold coronaviruses can protect us from coronavirus disease 2019 (COVID-19) – and reveals that this may actually put certain individuals at risk of more severe clinical presentations.

8 Mar 2022

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

Researchers describe a method to safely sanitize an occupied room using ultraviolet (UV)-C radiation.

8 Mar 2022

A new view of SARS-CoV-2 genome structure

Researchers performed DMS mutational profiling with sequencing and DREEM clustering to determine the SARS-CoV-2 RNA secondary structure.

8 Mar 2022

SARS News and Research

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

The relationship between highly conserved residues in the SARS CoV fusion peptide and their role in coordinating calcium binding for viral entry

High prevalence of new-onset diabetes with ketoacidosis observed in children during COVID-19 pandemic

A predictive model for COVID-19 outcomes

CRIPSR identifies cell-type-specific ACE2 modifiers

Increasing trend of antimicrobial resistance in Eastern Mediterranean Region of World Health Organization

Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

One California university has unified town and gown to fight covid. Why haven’t others?

Elevated P2X7 receptor levels in COVID-19 patients correlate with disease severity

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Assessment of oligonucleotides as COVID-19 treatment

Challenges and solutions for long-COVID

COVID-19 may cause brain shrinkage in some people

Study suggests recent common cold may actually lead to worse COVID-19 disease

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

A new view of SARS-CoV-2 genome structure

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News